Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Prevalence of restless legs syndrome in functional movement disorders: a case-control study from the Czech Republic

T. Serranová, M. Slovák, D. Kemlink, K. Šonka, M. Hallett, E. Růžička,

. 2019 ; 9 (1) : e024236. [pub] 20190121

Language English Country Great Britain

Document type Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't

Grant support
NV16-29651A MZ0 CEP Register

OBJECTIVES: The prevalence of restless legs syndrome (RLS) in functional movement disorders (FMD) is not known. Patients with FMD often present with multiple motor and sensory symptoms. Some of these symptoms might be due to comorbid RLS. Therefore, our objective was to evaluate possible association between FMD and RLS. DESIGN: Case-control study. SETTING: Movement Disorders Center, 1st Faculty of Medicine and General University Hospital in Prague, Czech Republic. PARTICIPANTS: 96 consecutive patients with clinically established FMD (80 females, mean age (SD) 45.0 (13) years), and 76 matched controls. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measure was prevalence of RLS based on updated International RLS Study Group criteria. Secondary outcome measures included prevalence of periodic limb movements (PLM) using actigraphy; pain, motor and sensory symptoms in lower limbs; organic comorbidities and medication affecting RLS. RESULTS: RLS criteria were fulfilled in 43.8% of patients (95% CI 34 to 54) and in 7.9% of controls (95% CI 3 to 17, p<0.00001). Both RLS and PLM indices (PLMi) ≥22.5/hour were found in 21.2% of patients with FMD and 2.6% of controls. Patients with FMD with RLS had a higher mean PLMi (p<0.001) and a higher proportion of PLMi ≥22.5/hour (p<0.01) than RLS-negative patients. Patients with RLS had higher prevalence of pain and sensory symptoms in lower limbs, no difference was found in medication and prevalence of organic comorbidities in patients with FMD with and without RLS. CONCLUSIONS: We found an increased prevalence of RLS in patients with FMD. Clinical diagnosis of RLS was supported by actigraphic measurement of clinically relevant PLM in a significant proportion of patients with FMD. Although functional motor and sensory symptoms may mimic RLS, RLS may be unrecognised in patients with FMD. This finding may have clinical implications in management of FMD, and it raises the possibility of common pathophysiological mechanisms of FMD and RLS/PLM.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006628
003      
CZ-PrNML
005      
20211116134911.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmjopen-2018-024236 $2 doi
035    __
$a (PubMed)30670516
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Serranová, Tereza $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
245    10
$a Prevalence of restless legs syndrome in functional movement disorders: a case-control study from the Czech Republic / $c T. Serranová, M. Slovák, D. Kemlink, K. Šonka, M. Hallett, E. Růžička,
520    9_
$a OBJECTIVES: The prevalence of restless legs syndrome (RLS) in functional movement disorders (FMD) is not known. Patients with FMD often present with multiple motor and sensory symptoms. Some of these symptoms might be due to comorbid RLS. Therefore, our objective was to evaluate possible association between FMD and RLS. DESIGN: Case-control study. SETTING: Movement Disorders Center, 1st Faculty of Medicine and General University Hospital in Prague, Czech Republic. PARTICIPANTS: 96 consecutive patients with clinically established FMD (80 females, mean age (SD) 45.0 (13) years), and 76 matched controls. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measure was prevalence of RLS based on updated International RLS Study Group criteria. Secondary outcome measures included prevalence of periodic limb movements (PLM) using actigraphy; pain, motor and sensory symptoms in lower limbs; organic comorbidities and medication affecting RLS. RESULTS: RLS criteria were fulfilled in 43.8% of patients (95% CI 34 to 54) and in 7.9% of controls (95% CI 3 to 17, p<0.00001). Both RLS and PLM indices (PLMi) ≥22.5/hour were found in 21.2% of patients with FMD and 2.6% of controls. Patients with FMD with RLS had a higher mean PLMi (p<0.001) and a higher proportion of PLMi ≥22.5/hour (p<0.01) than RLS-negative patients. Patients with RLS had higher prevalence of pain and sensory symptoms in lower limbs, no difference was found in medication and prevalence of organic comorbidities in patients with FMD with and without RLS. CONCLUSIONS: We found an increased prevalence of RLS in patients with FMD. Clinical diagnosis of RLS was supported by actigraphic measurement of clinically relevant PLM in a significant proportion of patients with FMD. Although functional motor and sensory symptoms may mimic RLS, RLS may be unrecognised in patients with FMD. This finding may have clinical implications in management of FMD, and it raises the possibility of common pathophysiological mechanisms of FMD and RLS/PLM.
650    _2
$a dospělí $7 D000328
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a konverzní poruchy $x epidemiologie $x patofyziologie $7 D003291
650    _2
$a dystonie $x patofyziologie $7 D004421
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a neurologické poruchy chůze $x patofyziologie $7 D020233
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pohybové poruchy $x epidemiologie $x patofyziologie $7 D009069
650    _2
$a svalová slabost $x patofyziologie $7 D018908
650    _2
$a myoklonus $x patofyziologie $7 D009207
650    _2
$a poruchy hybnosti oka $x patofyziologie $7 D015835
650    _2
$a prevalence $7 D015995
650    _2
$a syndrom neklidných nohou $x epidemiologie $7 D012148
650    _2
$a poruchy řeči $x patofyziologie $7 D013064
650    _2
$a tremor $x patofyziologie $7 D014202
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Slovák, Matěj, $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic. $d 1987- $7 xx0264369
700    1_
$a Kemlink, David $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Šonka, Karel $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Hallett, Mark $u Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
700    1_
$a Růžička, Evžen $u Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
773    0_
$w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 9, č. 1 (2019), s. e024236
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30670516 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20211116134912 $b ABA008
999    __
$a ok $b bmc $g 1525486 $s 1096684
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 1 $d e024236 $e 20190121 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
GRA    __
$a NV16-29651A $p MZ0
LZP    __
$a Pubmed-20200511

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...